Mackenzie Institute Keynote Speaker
Booth Lecture Theatre, Medical and Biological Sciences Building and Microsoft Teams
24th May 2022, 12.30pm - 1.30pm
The Mackenzie Institute are delighted to welcome Sir Harpal Kumar as a Keynote Speaker.
The title of Sir Harpal's presentation is;
Cancer Early Diagnosis - The role of Science and Business in Addressing a Critical Health Need
Sir Harpal is the President of GRAIL Europe and leads GRAIL's biopharma business globally. Prior to GRAIL, he was Senior Vice President and Head of Innovation EMEA at Johnson & Johnson. Before joining J&J, Sir Harpal spent more than 15 years with Cancer Research UK and served as the organisation's Chief Executive Officer from April 2007 until June 2018. Prior to this, he was Chief Executive of Cancer Research Technology (a subsidiary of CRUK). Before CRUK, he worked with McKinsey & Co, and was CEO of the Papworth Trust and Nexan Group.
Sir Harpal received a first-class Masters in Chemical Engineering from the University of Cambridge, and an MBA as a Baker Scholar from Harvard Business School. He has been awarded Honorary Doctorates from the Universities of Manchester, Newcastle and Glasgow, and the Institute of Cancer Research. He is an Honorary Fellow of the Academy of Medical Sciences, Royal College of Radiologists, Association of Cancer Physicians (UK) and St John's College, University of Cambridge. In 2016, he was knighted by Her Majesty Queen Elizabeth II for services to cancer research. He is a Board Member of Our Future Health and is a member of the Oversight Committee of the Covid-19 National Core Studies.